CL2008002749A1 - Metodo para analizar una muestra de fluido humano por puncion no venosa y no arterial o muestra celular, particularmente una muestra de fluido menstrual, para detectar la presencia de al menos una enfermedad infecciosa. - Google Patents

Metodo para analizar una muestra de fluido humano por puncion no venosa y no arterial o muestra celular, particularmente una muestra de fluido menstrual, para detectar la presencia de al menos una enfermedad infecciosa.

Info

Publication number
CL2008002749A1
CL2008002749A1 CL2008002749A CL2008002749A CL2008002749A1 CL 2008002749 A1 CL2008002749 A1 CL 2008002749A1 CL 2008002749 A CL2008002749 A CL 2008002749A CL 2008002749 A CL2008002749 A CL 2008002749A CL 2008002749 A1 CL2008002749 A1 CL 2008002749A1
Authority
CL
Chile
Prior art keywords
fluid sample
sample
arterial
infectious disease
analyzing
Prior art date
Application number
CL2008002749A
Other languages
English (en)
Inventor
Mercedes A Walton
Julie G Allickson
Original Assignee
Cryo Cell Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryo Cell Int Inc filed Critical Cryo Cell Int Inc
Publication of CL2008002749A1 publication Critical patent/CL2008002749A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Método para analizar una muestra de fluido humano por punción no venosa y no arterial o muestra celular para detectar la presencia de al menos, una enfermedad infecciosa.
CL2008002749A 2007-09-14 2008-09-15 Metodo para analizar una muestra de fluido humano por puncion no venosa y no arterial o muestra celular, particularmente una muestra de fluido menstrual, para detectar la presencia de al menos una enfermedad infecciosa. CL2008002749A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99374807P 2007-09-14 2007-09-14
US19160108P 2008-09-09 2008-09-09

Publications (1)

Publication Number Publication Date
CL2008002749A1 true CL2008002749A1 (es) 2010-05-07

Family

ID=40452371

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002749A CL2008002749A1 (es) 2007-09-14 2008-09-15 Metodo para analizar una muestra de fluido humano por puncion no venosa y no arterial o muestra celular, particularmente una muestra de fluido menstrual, para detectar la presencia de al menos una enfermedad infecciosa.

Country Status (15)

Country Link
EP (1) EP2200620A4 (es)
JP (1) JP2010539479A (es)
KR (1) KR20100063089A (es)
CN (1) CN101854942A (es)
AR (1) AR068449A1 (es)
AU (1) AU2008299884A1 (es)
BR (1) BRPI0817333A2 (es)
CA (1) CA2699491A1 (es)
CL (1) CL2008002749A1 (es)
CR (1) CR11315A (es)
EC (1) ECSP10010048A (es)
MX (1) MX2010002910A (es)
NI (1) NI201000037A (es)
TW (1) TW200918020A (es)
WO (1) WO2009035706A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2916520A1 (en) * 2013-07-03 2015-01-08 Coyne Ip Holdings, Llc Methods for predicting responses to chemical or biologic substances
GB2543728B (en) 2014-08-12 2019-04-17 Nextgen Jane Inc Medical kit and method for processing a biological sample
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725481A (en) * 1996-05-17 1998-03-10 A. Fem Medical Corporation Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
US20080241113A1 (en) * 2007-03-01 2008-10-02 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of endometrial/menstrual cells

Also Published As

Publication number Publication date
EP2200620A4 (en) 2010-10-27
KR20100063089A (ko) 2010-06-10
AU2008299884A1 (en) 2009-03-19
AR068449A1 (es) 2009-11-18
BRPI0817333A2 (pt) 2017-06-13
CR11315A (es) 2010-08-13
WO2009035706A1 (en) 2009-03-19
MX2010002910A (es) 2010-05-24
CA2699491A1 (en) 2009-03-19
ECSP10010048A (es) 2010-06-29
NI201000037A (es) 2011-06-21
JP2010539479A (ja) 2010-12-16
EP2200620A1 (en) 2010-06-30
CN101854942A (zh) 2010-10-06
TW200918020A (en) 2009-05-01

Similar Documents

Publication Publication Date Title
LTC2358756I2 (lt) Žmogaus antikūnai, pasižymintys dideliu giminingumu pcsk9
BR112013010952A2 (pt) sistemas de rmn e métodos para a detecção rápida de analisados
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
BRPI0917120A2 (pt) método, e, meio legível por computador.
BRPI0812384A2 (pt) Métodos de tratamento, diagnóstico e detecção de distúrbios associados a fgf21
BRPI1014765A2 (pt) microesferas de amplificação de sinal, seu uso em procedimento de amplificação analítica de uma etapa e multietapa e métodos para sua produção.
WO2011106536A3 (en) Methods of diagnosing infectious disease pathogens and their drug sensitivity
DE602005017840D1 (de) Blutdruckmonitor
DE502005003934D1 (de) Spritze, insbesondere für medizinische Anwendungen
DE602006002756D1 (de) Manschette für Blutdruckmessgerät, Herstellungsverfahren hierfür und Blutdruckmessgerät
ITMI20050127A1 (it) Bracciale regolabile per la misurazione della pressione sanguigna
IT1395285B1 (it) Pistone e procedimento per la sua fabbricazione.
PA8796101A1 (es) Analisis de enfermedades infecciosas en fluido menstrual, celulas endometriales/menstruales, fluido amniotico, sangre de cordon umbilical u otras muestras
ATE474228T1 (de) Reagenz für hämoglobinabbau
BR112012005733A2 (pt) métodos de canal de fluido de filtro de sangue, dispositivos e sistemas.
BRPI0919694A2 (pt) composto, composto farmacêutica, uso de um composto, e, método de tratamento de uma doença.
CL2008002749A1 (es) Metodo para analizar una muestra de fluido humano por puncion no venosa y no arterial o muestra celular, particularmente una muestra de fluido menstrual, para detectar la presencia de al menos una enfermedad infecciosa.
BRPI0717507A2 (pt) métodos para tratar, prevenir e diagnosticar infecção ttv de porcine
DE502006004622D1 (de) Messverfahren und -system für bauteile, insbesondere für kolben von kolbenmaschinen
DE602006007833D1 (de) Blutdrucksenkende proteinhydrolysate
AT10509U3 (de) Behandlungsvorrichtung für lebewesen, insbesondere grosstiere
BRPI0717597B8 (pt) método de identificar e diagnosticar trypanosoma cruzi bem como fase sólida
DE602004006850D1 (de) Tampon, insbesondere für frauen
DE202005018190U1 (de) Körperschutzpanzerung, insbesondere für den Stichschutz
BR112012000018A2 (pt) processo de inativação de, pelo menos, um agente patogênico em uma amostra de plasma sanguíneo humano.